Reirradiation in primary or secondary brain tumors;Réirradiation cérébrale des tumeurs primitives malignes ou secondaires

Cancer/Radiotherapie

Volumn 14, Issue 6-7, 2010, Pages 421-437

  Noel G ^a   Mazeron, J J ^b  

^a CENTRE PAUL STRAUSS   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

3D conformal radiotherapy; High grade glioma; Metastases; Stereotactic radiotherapy

Indexed keywords

BRAIN METASTASIS; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; GLIOMA; HUMAN; PRIORITY JOURNAL; RADIATION DOSE; SHORT SURVEY; STEREOTACTIC BODY RADIATION THERAPY; STEREOTACTIC RADIOSURGERY; SURVIVAL RATE; ADOLESCENT; ADULT; AGED; BRAIN; BRAIN EDEMA; BRAIN TUMOR; CARCINOMA; CHILD; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; METASTASIS; METHODOLOGY; MIDDLE AGED; PRESCHOOL CHILD; PROGNOSIS; RADIATION DOSE FRACTIONATION; RADIATION EXPOSURE; RADIATION INJURY; RADIOSURGERY; RADIOTHERAPY; RETROSPECTIVE STUDY; REVIEW; SKULL IRRADIATION; TUMOR RECURRENCE;

CORTICOSTEROID;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; BRAIN; BRAIN EDEMA; BRAIN NEOPLASMS; CARCINOMA; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; CRANIAL IRRADIATION; DOSE FRACTIONATION; GLIOMA; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIATION INJURIES; RADIOSURGERY; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 77958154927     PISSN: 12783218     EISSN: 17696658     Source Type: Journal    
DOI: 10.1016/j.canrad.2010.06.014     Document Type: Short Survey

References (83)

1. Akyurek S., Chang E.L., Mahajan A., Hassenbusch S.J., Allen P.K., Mathews L.A., et al. Stereotactic radiosurgical treatment of cerebral metastases arising from breast cancer. Am J Clin Oncol 2007, 30:310-314.
2. Alexander E., Loeffler J.S. Radiosurgery using a modified linear accelerator. Neurosurg Clin N Am 1992, 3:167-190.
3. Andrews D.W., Scott C.B., Sperduto P.W., Flanders A.E., Gaspar L.E., Schell M.C., et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004, 363:1665-1672.
4. Aoyama H., Tago M., Kato N., Toyoda T., Kenjyo M., Hirota S., et al. Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys 2007, 68:1388-1395.
5. Arcicasa M., Roncadin M., Bidoli E., Dedkov A., Gigante M., Trovo M.G. Reirradiation and lomustine in patients with relapsed high-grade gliomas. Int J Radiat Oncol Biol Phys 1999, 43:789-793.
6. Asai A., Matsutani M., Kohno T., Nakamura O., Tanaka H., Fujimaki T., et al. Subacute brain atrophy after radiation therapy for malignant brain tumor. Cancer 1989, 63:1962-1974.
7. Auperin A., Arriagada R., Pignon J.P., Le Péchoux C., Gregor A., Stephens R.J., et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. N Engl J Med 1999, 341:476-484.
8. Bauman G.S., Sneed P.K., Wara W.M., Stalpers L.J., Chang S.M., McDermott M.W., et al. Reirradiation of primary CNS tumors. Int J Radiat Oncol Biol Phys 1996, 36:433-441.
9. Brem H., Piantadosi S., Burger P.C., Walker M., Selker R., Vick N.A., et al. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. Lancet 1995, 345:1008-1012.
10. Chamberlain M.C., Barba D., Kormanik P., Shea W.M. Stereotactic radiosurgery for recurrent gliomas. Cancer 1994, 74:1342-1347.
11. Chen J.C., Petrovich Z., Giannotta S.L., Yu C., Apuzzo M.L. Radiosurgical salvage therapy for patients presenting with recurrence of metastatic disease to the brain. Neurosurgery 2000, 46. [discussion 6-7].
12. Chinot O.L., Honore S., Dufour H., Barrie M., Figarella-Branger D., Muracciole X., et al. Safety and efficacy of temozolomide in patients with recurrent anaplastic oligodendrogliomas after standard radiotherapy and chemotherapy. J Clin Oncol 2001, 19:2449-2455.
13. Cho K.H., Hall W.A., Gerbi B.J., Higgins P.D., McGuire W.A., Clark H.B. Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas. Int J Radiat Oncol Biol Phys 1999, 45:1133-1141.
14. Combs S.E., Schulz-Ertner D., Thilmann C., Edler L., Debus J. Treatment of cerebral metastases from breast cancer with stereotactic radiosurgery. Strahlenther Onkol 2004, 180:590-596.
15. Combs S.E., Thilmann C., Edler L., Debus J., Schulz-Ertner D. Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution. J Clin Oncol 2005, 23:8863-8869.
16. Cooper J.S., Steinfeld A.D., Lerch I.A. Cerebral metastases: value of reirradiation in selected patients. Radiology. 1990, 174:883-885.
17. Curran W.J., Scott C.B., Horton J., Nelson J.S., Weinstein A.S., Fischbach A.J., et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 1993, 85:704-710.
18. Daumas-Duport C., Blond S., Vedrenne C., Szikla G. Radiolesion versus recurrence: bioptic data in 39 gliomas after interstitial and external radiation treatment. Acta Neurochir Suppl (Wien) 1984, 33:291-299.
19. Davey P., O'Brien P.F., Schwartz M.L., Cooper P.W. A phase I/II study of salvage radiosurgery in the treatment of recurrent brain metastases. Br J Neurosurg 1994, 8:717-723.
20. Davey P., Schwartz M.L., Scora D., Gardner S., O'Brien P.F. Fractionated (split dose) radiosurgery in patients with recurrent brain metastases: implications for survival. Br J Neurosurg 2007, 21:491-495.
21. DeAngelis L.M., Delattre J.Y., Posner J.B. Radiation-induced dementia in patients cured of brain metastases. Neurology 1989, 39:789-796.
22. Dirks P., Bernstein M., Muller P.J., Tucker W.S. The value of reoperation for recurrent glioblastoma. Can J Surg 1993, 36:271-275.
23. Emami B., Lyman J., Brown A., Coia L., Goitein M., Munzenrider J.E., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991, 21:109-122.
24. Ernst-Stecken A., Ganslandt O., Lambrecht U., Sauer R., Grabenbauer G. Survival and quality of life after hypofractionated stereotactic radiotherapy for recurrent malignant glioma. J Neurooncol 2007, 81:287-294.
25. Flickinger J.C., Deutsch M., Lunsford L.D. Repeat megavoltage irradiation of pituitary and suprasellar tumors. Int J Radiat Oncol Biol Phys 1989, 17:171-175.
26. Fokas E., Wacker U., Gross M.W., Henzel M., Encheva E., Engenhart-Cabillic R. Hypofractionated stereotactic reirradiation of recurrent glioblastomas: a beneficial treatment option after high-dose radiotherapy?. Strahlenther Onkol 2009, 185:235-240.
27. Glass J., Silverman C.L., Axelrod R., Corn B.W., Andrews D.W. Fractionated stereotactic radiotherapy with cis-platinum radiosensitization in the treatment of recurrent, progressive, or persistent malignant astrocytoma. Am J Clin Oncol 1997, 20:226-229.
28. Grant R. Overview: Brain tumour diagnosis and management/Royal College of Physicians guidelines. J Neurol Neurosurg Psychiatry 2004, 75:ii18-ii23.
29. Grosu A.L., Weber W.A., Franz M., Stark S., Piert M., Thamm R., et al. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. Int J Radiat Oncol Biol Phys 2005, 63:511-519.
30. Guiu S., Taillibert S., Chinot O., Taillandier L., Honnorat J., Dietrich P.Y., et al. Bevacizumab/Irinotecan. Un nouveau traitement actif dans les gliomes de haut grade récidivants: résultats préliminaires d'une étude multicentrique de l'Anocef. Rev Neurol (Paris) 2008, 164:588-594.
31. Gutin P.H., Iwamoto F.M., Beal K., Mohile N.A., Karimi S., Hou B.L., et al. Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas. Int J Radiat Oncol Biol Phys 2009, 75:156-163.
32. Hall W.A., Djalilian H.R., Sperduto P.W., Cho K.H., Gerbi B.J., Gibbons J.P., et al. Stereotactic radiosurgery for recurrent malignant gliomas. J Clin Oncol 1995, 13:1642-1648.
33. Harsh GRt, Levin V.A., Gutin P.H., Seager M., Silver P., Wilson C.B. Reoperation for recurrent glioblastoma and anaplastic astrocytoma. Neurosurgery 1987, 21:615-621.
34. Hayat K., Jones B., Bisbrown G., Baria K., Pigott T. Retreatment of patients with intracranial gliomas by external beam radiotherapy and cytotoxic chemotherapy. Clin Oncol (R Coll Radiol) 1997, 9:158-163.
35. Hoffman R., Sneed P.K., McDermott M.W., Chang S., Lamborn K.R., Park E., et al. Radiosurgery for brain metastases from primary lung carcinoma. Cancer J 2001, 7:121-131.
36. Hudes R.S., Corn B.W., Werner-Wasik M., Andrews D., Rosenstock J., Thoron L., et al. A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma. Int J Radiat Oncol Biol Phys 1999, 43:293-298.
37. Keime-Guibert F., Chinot O., Taillandier L., Cartalat-Carel S., Frenay M., Kantor G., et al. Radiotherapy for glioblastoma in the elderly. N Engl J Med 2007, 356:1527-1535.
38. Kim H.K., Thornton A.F., Greenberg H.S., Page M.A., Junck L., Sandler H.M. Results of reirradiation of primary intracranial neoplasms with three-dimensional conformal therapy. Am J Clin Oncol 1997, 20:358-363.
39. Kohshi K., Yamamoto H., Nakahara A., Katoh T., Takagi M. Fractionated stereotactic radiotherapy using gamma unit after hyperbaric oxygenation on recurrent high-grade gliomas. J Neurooncol 2007, 82:297-303.
40. Kondziolka D., Flickinger J.C., Bissonette D.J., Bozik M., Lunsford L.D. Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms. Neurosurgery 1997, 41. [discussion 83-5].
41. Kwon K.Y., Kong D.S., Lee J.I., Nam D.H., Park K., Kim J.H. Outcome of repeated radiosurgery for recurrent metastatic brain tumors. Clin Neurol Neurosurg 2007, 109:132-137.
42. Laing R.W., Warrington A.P., Graham J., Britton J., Hines F., Brada M. Efficacy and toxicity of fractionated stereotactic radiotherapy in the treatment of recurrent gliomas (phase I/II study). Radiother Oncol 1993, 27:22-29.
43. ® for glioma: selection factors and survival. Int J Radiat Oncol Biol Phys 1996, 36:1045-1053.
44. ® radiosurgery and marimastat in patients with recurrent malignant glioma. Int J Radiat Oncol Biol Phys 2002, 54:1397-1404.
45. Lawrence Y.R., Li X.A., el-Naqa I., Hahn C.A., Marks L.B., Merchant T.E., et al. Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys 2010, 76:S20-S27.
46. Lederman G., Arbit E., Odaimi M., Lombardi E., Wrzolek M., Wronski M. Fractionated stereotactic radiosurgery and concurrent taxol in recurrent glioblastoma multiforme: a preliminary report. Int J Radiat Oncol Biol Phys 1998, 40:661-666.
47. Lederman G., Wronski M., Arbit E., Odaimi M., Wertheim S., Lombardi E., et al. Treatment of recurrent glioblastoma multiforme using fractionated stereotactic radiosurgery and concurrent paclitaxel. Am J Clin Oncol 2000, 23:155-159.
48. Loeffler J.S., Kooy H.M., Wen P.Y., Fine H.A., Cheng C.W., Mannarino E.G., et al. The treatment of recurrent brain metastases with stereotactic radiosurgery. J Clin Oncol 1990, 8:576-582.
49. Mayer R., Sminia P. Reirradiation tolerance of the human brain. Int J Radiat Oncol Biol Phys 2008, 70:1350-1360.
50. Nieder C., Nestle U., Niewald M., Walter K., Schnabel K. Hyperfractionated reirraidation for malignant glioma. Front Radiat Ther Oncol 1999, 33:150-157.
51. Noël G., Ben Ammar C.N., Feuvret L., Valéry C.A., Cornu P., Boisserie G., et al. Résultats de l'irradiation en conditions stéréotaxiques de rattrapage de 14 patients atteints d'un gliome de grade III ou IV. Rev Neurol (Paris) 2004, 160:539-545.
52. Noël G., Boisserie G., Feuvret L., Mazeron J.J. La radiothérapie en conditions stéréotaxiques des métastases cérébrales : réflexions, controverses et questions sans réponse en 2004. Bull Cancer 2004, 91:81-93.
53. Noël G., Bollet M.A., Noël S., Feuvret L., Boisserie G., Tep B., et al. Linac stereotactic radiosurgery: an effective and safe treatment for elderly patients with brain metastases. Int J Radiat Oncol Biol Phys 2005, 63:1555-1561.
54. Noël G., Medioni J., Valéry C.A., Boisserie G., Simon J.M., Cornu P., et al. Three irradiation treatment options including radiosurgery for brain metastases from primary lung cancer. Lung Cancer 2003, 41:333-343.
55. Noël G., Proudhom M.A., Valéry C.A., Cornu P., Boisserie G., Hasboun D., et al. Radiosurgery for reirradiation of brain metastasis: results in 54 patients. Radiother Oncol 2001, 60:61-67.
56. Noël G., Quétin P., Heymann S., Karamanoukian D., Schott R. Les délais au diagnostic et à la mise en traitement n'altèrent pas les résultats des traitements délivrés aux patients atteints de glioblastome. Cancer Radiother 2009, 13:17-23.
57. Noël G., Simon J.M., Valéry C.A., Cornu P., Boisserie G., Ledu D., et al. Linac radiosurgery for brain metastasis of melanoma. Stereotact Funct Neurosurg 2002, 79:245-255.
58. Noël G., Valéry C.A., Boisserie G., Cornu P., Hasboun D., Marc Simon J., et al. LINAC radiosurgery for brain metastasis of renal cell carcinoma. Urol Oncol 2004, 22:25-31.
59. Park J.L., Suh J.H., Barnett G.H., Reddy C.A., Peereboom D.M., Stevens G.H.J., et al. Survival after stereotactic radiosurgery for recurrent glioblastoma multiforme. J Radiosurg 2000, 3:169-175.
60. Patchell R.A., Tibbs P.A., Regine W.F., Dempsey R.J., Mohiuddin M., Kryscio R.J., et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 1998, 280:1485-1489.
61. Patel M., Siddiqui F., Jin J.Y., Mikkelsen T., Rosenblum M., Movsas B., et al. Salvage reirradiation for recurrent glioblastoma with radiosurgery: radiographic response and improved survival. J Neurooncol 2009, 92:185-191.
62. Sadikov E., Bezjak A., Yi Q.L., Wells W., Dawson L., Millar B.A., et al. Value of whole brain reirradiation for brain metastases--single centre experience. Clin Oncol (R Coll Radiol) 2007, 19:532-538.
63. Schwer A.L., Damek D.M., Kavanagh B.D., Gaspar L.E., Lillehei K., Stuhr K., et al. A phase I dose-escalation study of fractionated stereotactic radiosurgery in combination with gefitinib in patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys 2008, 70:993-1001.
64. Selch M.T., DeSalles A.A.F., Solberg T.D., Wallace R.E., Do T.M., Ford J., et al. Hypofractionated sterotactic radiotherapy for recurrent malignant glioma. J Radiosurg 2000, 3:3-12.
65. Sheehan J., Kondziolka D., Flickinger J., Lunsford L.D. Radiosurgery for patients with recurrent small cell lung carcinoma metastatic to the brain: outcomes and prognostic factors. J Neurosurg 2005, 102:247-254.
66. Shenouda G., Souhami L., Podgorsak E.B., Bahary J.P., Villemure J.G., Caron J.L., et al. Radiosurgery and accelerated radiotherapy for patients with glioblastoma. Can J Neurol Sci 1997, 24:110-115.
67. Shepherd S.F., Laing R.W., Cosgrove V.P., Warrington A.P., Hines F., Ashley S.E., et al. Hypofractionated stereotactic radiotherapy in the management of recurrent glioma. Int J Radiat Oncol Biol Phys 1997, 37:393-398.
68. Shrieve D.C., Alexander E., Black P.M., Wen P.Y., Fine H.A., Kooy H.M., et al. Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome. J Neurosurg 1999, 90:72-77.
69. Shrieve D.C., Alexander E., Wen P.Y., Fine H.A., Kooy H.M., Black P.M., et al. Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme. Neurosurgery 1995, 36. [discussion 82-4].
70. ® radiosurgery for multiple metastatic brain tumours. Acta Neurochir (Wien) 2004, 146. [discussion 93].
71. Silbergeld D.L., Griffin B.R., Ojemann G.A. Reirradiation for recurrent cerebral astrocytoma. J Neurooncol 1992, 12:145-151.
72. Simon J.M., Cornu P., Boisserie G., Hasboun D., Tep B., Hardiman C., et al. Brachytherapy of glioblastoma recurring in previously irradiated territory: predictive value of tumor volume. Int J Radiat Oncol Biol Phys 2002, 53:67-74.
73. Soussain C., Ricard D., Fike J.R., Mazeron J.J., Psimaras D., Delattre J.Y. CNS complications of radiotherapy and chemotherapy. Lancet 2009, 374:1639-1651.
74. Stupp R., Mason W.P., van den Bent M.J., Weller M., Fisher B., Taphoorn M.J., et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005, 352:987-996.
75. Tsao M.N., Mehta M.P., Whelan T.J., Morris D.E., Hayman J.A., Flickinger J.C., et al. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma. Int J Radiat Oncol Biol Phys 2005, 63:47-55.
76. Ulm A.J., Friedman W.A., Bradshaw P., Foote K.D., Bova F.J. Radiosurgery in the treatment of malignant gliomas: the University of Florida experience. Neurosurgery 2005, 57. [discussion-7].
77. van Kampen M., Engenhart-Cabillic R., Debus J., Fuss M., Rhein B., Wannenmacher M. [The radiosurgery of glioblastoma multiforme in cases of recurrence. The Heidelberg experiences compared to the literature]. Strahlenther Onkol 1998, 174:19-24.
78. Veninga T., Langendijk H.A., Slotman B.J., Rutten E.H., van der Kogel A.J., Prick M.J., et al. Reirradiation of primary brain tumours: survival, clinical response and prognostic factors. Radiother Oncol 2001, 59:127-137.
79. Vordermark D., Kolbl O., Ruprecht K., Vince G.H., Bratengeier K., Flentje M. Hypofractionated stereotactic reirradiation: treatment option in recurrent malignant glioma. BMC Cancer 2005, 5:55.
80. Voynov G., Kaufman S., Hong T., Pinkerton A., Simon R., Dowsett R. Treatment of recurrent malignant gliomas with stereotactic intensity modulated radiation therapy. Am J Clin Oncol 2002, 25:606-611.
81. Wong W.W., Schild S.E., Sawyer T.E., Shaw E.G. Analysis of outcome in patients reirradiated for brain metastases. Int J Radiat Oncol Biol Phys 1996, 34:585-590.
82. Wurm R.E., Kuczer D.A., Schlenger L., Matnjani G., Scheffler D., Cosgrove V.P., et al. Hypofractionated stereotactic radiotherapy combined with topotecan in recurrent malignant glioma. Int J Radiat Oncol Biol Phys 2006, 66:S26-S32.
83. ® radiosurgery for recurrent cases. Stereotact Funct Neurosurg 1999, 72:73-80.